Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Feb 1;23(5):853–856. doi: 10.1016/j.bbmt.2017.01.082

Figure 1.

Figure 1

Post allogeneic transplantation rates of NRM (1a), disease relapse/progression (1a), progression-free survival (PFS) (1b) and overall survival (OS) (1b) in patients with aggressive NK-cell leukemia (ANKL). Post allogeneic transplantation outcomes of ANKL patients in complete remission vs. those with active disease: PFS (1c) and OS (1d).